RN7SL263P

Across TCGA pan-cancer cohorts, RN7SL263P RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RN7SL263P data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RN7SL263P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL263P expression acts as an unfavorable survival marker, although some lineages such as READ and LAML show a favorable association.

UVM, READ, and ACC are the cancer types where RN7SL263P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	OS	Quartile	All	0.318	1.000	<.001	67	view →
READ	DFS	Tertile	III,IV	0.640	0.198	.001	48	view →
ACC	OS	Tertile	IV	0.464	0.968	.001	35	view →
KIRC	DFS	Quartile	All	0.764	0.913	.005	25	view →
THCA	DFS	Quartile	III,IV	0.850	1.000	.006	20	view →
LAML	DFS	Median	All	0.469	0.281	.007	18	view →
LUAD	DFS	Median	IV	0.406	0.817	.007	18	view →
OV	OS	Median	IV	0.600	0.874	.006	14	view →
ESCA	OS	Median	IV	0.222	0.698	.006	12	view →
LGG	OS	Quartile	All	0.859	0.716	.021	10	view →
SARC	DFS	Quartile	All	0.403	0.648	.005	8	view →
HNSC	DFS	Quartile	IV	0.719	0.549	.010	5	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

RN7SL263P–UVM (OS)

Open the UVM breakdown →